Corcept sells treatment for Cushing's syndrome.
Corcept Therapeutics Incorporated (CORT) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:08 ET. Consensus EPS estimate is $0.81.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-30 | FY2026 Q1 | $-0.11 | $-0.30 | -172.3% | $164.90M |
| 2026-02-24 | FY2025 Q4 | $0.33 | $0.23 | -30.3% | $202.12M |
| 2025-11-04 | FY2025 Q3 | $0.18 | $0.19 | +5.6% | $207.64M |
| 2025-07-31 | FY2025 Q2 | $0.23 | $0.33 | +43.5% | $194.43M |
| 2025-05-05 | FY2025 Q1 | $0.17 | $0.19 | +11.8% | $157.21M |
| 2025-02-26 | FY2024 Q4 | $0.37 | $0.29 | -21.6% | $181.89M |
| 2024-10-30 | FY2024 Q3 | $0.28 | $0.45 | +60.7% | $182.55M |
| 2024-07-29 | FY2024 Q2 | $0.23 | $0.34 | +47.8% | $163.80M |
CORT has beaten consensus EPS in 5 of its last 8 reported quarters.
See CORT on the live calendar →